dMatrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for the identification of nontuberculous mycobacterial (NTM) isolates was evaluated in this study. Overall, 125 NTM isolates were analyzed by MALDI-TOF and GenoType CM/AS. Identification by 16S rRNA/hsp65 sequencing was considered the gold standard. Agreements between MALDI-TOF and GenoType CM/AS with the reference method were, respectively, 94.4% and 84.0%. In 17 cases (13.6%), results provided by GenoType and MALDI-TOF were discordant; however, the reference method agreed with MALDI-TOF in 16/17 cases (94.1%; P ؍ 0.002).
Identification of nontuberculous mycobacteria (NTM) by conventional phenotypic tests requires long incubation periods that may take up to 12 weeks. The GenoType Mycobacterium CM/AS (Hain Lifescience GmbH, Nehren, Germany) is a test based on the amplification of a 23S rRNA gene region followed by reverse hybridization with specific probes that allows the identification of 40 of the most common NTM. However, the hybridization step requires high sequence homology, and even point mutations in the target regions may hamper the hybridization step, leading to unreliable results (1). Matrix-assisted laser desorption ionizationtime of flight (MALDI-TOF) has been recently applied to the identification of a wide range of microorganisms (2), mainly clinically significant bacteria and fungi. Experience with MALDI-TOF for the rapid identification of NTM is very limited, mainly because of the number of identified species and because database information is scarce (3-5). In this study, a large collection of NTM clinical isolates and reference strains were analyzed using MALDI-TOF technology in comparison with the GenoType Mycobacterium CM/AS procedure and the reference procedure, 16S rRNA/hsp65 gene sequencing.From January 2010 to September 2014, all the NTM with purportedly clinical significance were grown on Lowenstein-Jensen agar and simultaneously identified by GenoType CM/AS assay (Hain Lifescience, GmbH, Nehren, Germany) and with MALDI-TOF MS technology (Bruker Daltonics, Bremen, Germany). Ten reference isolates were also included in this study as positive controls (Table 1). All the strains were also analyzed by 16S rRNA/ hsp65 sequencing as the reference method in order to resolve possible discrepancies.Genotypic identification. Two gene regions were targeted for NTM identification: the 5= end of the 16S rRNA gene with the universal primers E8F (5=-AGAGTTTGATCCTGGCTCAG-3=) and E533R (5=-TTACCGCGGCTGCTGGCA-3=) (6) and a 439-bp fragment within the hsp65 gene using the primers TB11 (5=-ACCAACGATGGTGTGTCCAT) and TB12 (5=-CTTGTCGA ACCGCATACCCT), as described by Telenti et al. (7). The amplification, purification, and sequencing process was carried out as previously described by . Interpretation of sequencing results was performed considering CLSI recommendations for the genus Mycobacterium (9). Results obtained by 16S rRNA/hsp65 sequencing were considered the final microorganism identification.GenoType CM/AS iden...